Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
01/1987
01/13/1987US4636469 Isolation of hepatitis A virus strain HM-175
01/06/1987CA1216234A1 Preparation of modified strains of bovine diarrhoea virus and vaccines containing them
12/1986
12/31/1986WO1986007610A1 Expression of human il-2 in mammal cells by means of a recombined poxvirus
12/31/1986WO1986007609A1 VECTOR FOR THE EXPRESSION OF gamma-INTERFERON IN MAMMAL CELLS, METHOD FOR ITS IMPLEMENTATION, PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING THE gamma-INTERFERON
12/31/1986CN85103413A Process for the preparation of live virus purified vaccine
12/30/1986EP0206939A1 Expression of human IL-2 in mammalian cells by a recombined pox virus
12/30/1986EP0206920A1 Expression vector for gamma interferon in cells of mammals, process for its use, product obtained and pharmaceutical composition containing gamma interferon
12/04/1986WO1986007095A1 Nucleic acid probes for prenatal sexing
12/03/1986EP0203909A1 Early-summer meningo-encephalitis virus (FSME-virus) vaccine, and method of producing the same
12/03/1986EP0203177A1 Polypeptides and antibodies related to deglycosylated viral glycoproteins
12/02/1986CA1214724A1 Vaccine for bluetongue disease employing platinum compounds
11/1986
11/19/1986CN86102113A Process for preparing hepatitis b surface antigen containing particies in novel forms which are highly immunogenic
11/11/1986US4622222 Storage stability
11/04/1986US4620978 Hepatitis A virus purified and triply cloned
10/1986
10/22/1986EP0198328A2 Vaccinia DNA
10/22/1986EP0198299A2 A process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
10/21/1986US4618493 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
10/15/1986EP0197554A2 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
10/09/1986WO1986005806A1 Infectious bronchitis virus spike protein
10/08/1986EP0196515A1 Photodynamic inactivation of virus in therapeutic protein compositions
10/08/1986EP0196316A1 Hepatitis a virus purified and triply cloned
10/07/1986CA1212320A1 Ozone inactivated organisms as vaccines
10/01/1986CN86100726A Process for the preparation of canine parvovirus vaccines
09/1986
09/23/1986US4613501 Inactivation of viruses in labile blood derivatives
09/10/1986EP0022426B1 Nasal preparations, process for making same and their use
09/09/1986CA1211060A1 Viruses with recombinant surface proteins
09/03/1986EP0193284A1 A method for detecting HTLV-III neutralizing antibodies in sera
09/03/1986EP0192705A1 Detachment of anchorage-dependent cells from microcarriers
09/02/1986US4609548 Vaccines for pseudorabies disease and methods for use of same
08/1986
08/27/1986EP0192001A2 Papilloma virus probes and in vitro methods for the diagnosis of papilloma virus infections
08/27/1986CN85100276A Preparation technique for diagnostic hepatitis b e antigen (hbeag)
08/14/1986WO1986004613A1 A method for detecting htlv-iii neutralizing antibodies in sera
08/14/1986WO1986004589A1 Fsh
08/06/1986EP0189958A2 Canine parvovirus vaccines
08/06/1986EP0189841A2 Enzymatic detection of bacterial capsular polysaccharide antigens
07/1986
07/31/1986WO1986004423A1 Improvements relating to viral isolates and their use
07/31/1986WO1986004242A1 Improvements relating to influenza vaccine
07/29/1986US4603112 Modified vaccinia virus
07/23/1986EP0187894A1 A size selective catalyst comprising a fibrin gel
07/17/1986WO1986003971A1 Antiviral agents
06/1986
06/17/1986US4595593 Mixing terpene from cinnamon flower oil and cinnamic aldehyde with pharmaceutical carrier
06/11/1986EP0184331A2 Psoralen inactivation of human T-cell leukemia virus III (HTLV III)
06/05/1986WO1986003224A1 Polypeptides and antibodies related to deglycosylated viral glycoproteins
06/03/1986US4593002 Insertion of nucleotide into virus
06/03/1986US4592910 Preparation for deactivating viruses and process for producing same
05/1986
05/20/1986CA1204688A1 Method for cultivating insect cells
05/14/1986EP0181150A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
05/14/1986EP0181117A2 Oral vaccines
05/07/1986EP0180564A2 Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
05/06/1986US4587018 Fibrin gel
05/06/1986CA1204069A1 Temperature sensitive reassortant viruses and a vaccine against equine influenza
04/1986
04/24/1986WO1986002380A1 Cloning or expression vectors comprising the genome of the virus of fowl erythroblastosis and cells transfected by said vectors
04/23/1986EP0178996A1 Cloning or expression vectors containing the genome of avian Erythroblastosis virus and cells transfected by these vectors
04/15/1986CA1203169A1 Method of preparation of pure antigene hbs from human plasma
04/09/1986EP0177015A2 Processec for the preparation of Hepatitis B antigenic compositions
04/08/1986US4581231 Contacting with a halohydrocarbon solvent or treating agent
04/02/1986EP0176170A1 Herpes simplex virus as a vector
04/02/1986EP0175841A2 Method for the production of pertussis component vaccine and combined vaccine of pertussis antigen; diphtheria toxoid and tetanus toxoid
03/1986
03/27/1986WO1986001826A1 Hepatitis a virus purified and triply cloned
03/13/1986WO1986001531A1 Detachment of anchorage-dependent cells from microcarriers
03/12/1986EP0174228A1 Process for diagnosing human Papilloma virus infections, monoclonal antibodies specific for a type of human Papilloma virus, and hybridomalines secreting them
03/05/1986EP0173268A2 A method for the preparation of a herpes simplex virus subunit vaccine
02/1986
02/19/1986EP0171771A2 A method for purification of rabies virus
02/19/1986EP0171765A2 A method for purification of japanese encephalitis virus
02/18/1986US4571385 Human-animal rotovirus combination
02/18/1986CA1200772A1 Expression vectors of catechol 2,3-oxygenase, enzymes thus obtained and uses thereof
02/12/1986EP0171086A2 A method for purification of influenza virus
01/1986
01/28/1986US4567147 Attenuated smallpox vaccine strain
01/22/1986EP0168933A2 Detection and/or identification of microorganisms in a test sample using bioluminescence or other exogenous genetically-introduced marker
01/21/1986CA1199578A1 Tissue culture medium
12/1985
12/18/1985EP0165120A1 Lymphadenopathy-associated retrovirus adapted to continuous lymphoblastoid-B cell lines capable of continuously producing said retrovirus, and process for preparing the cell lines
12/17/1985US4559229 Avian proventriculitis vaccine
12/17/1985CA1198056A1 Inactivation of a lipid virus
12/10/1985US4558011 Method for preparation of pure hepatitis B surface antigen from human plasma
12/04/1985EP0163491A1 Yeast vector
12/03/1985US4556556 Vaccine for the prevention of vesicular stomatitis virus infection
11/1985
11/27/1985EP0162757A1 Vaccine for rabies and process for its preparation
11/21/1985EP0161328A1 Supported viral antigen and preparation and use thereof
11/12/1985US4552758 Human use of avian-human reassortants as vaccines for influenza A virus
11/12/1985US4552757 Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus
11/12/1985CA1196590A1 Hepatitis - a viruses adapted to human fibroblast cells
11/07/1985WO1985004897A1 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids
11/07/1985WO1985004810A1 Vaccine against rabies and preparation process thereof
11/06/1985EP0160091A1 Production of heterodimeric human fertility hormones
10/1985
10/30/1985EP0159743A1 Live purified Marek's disease vaccine
10/24/1985WO1985004588A1 Live purified marek's disease vaccine and process for the preparation thereof
10/16/1985EP0158285A2 Process for obtaining cell cultures
10/09/1985EP0157528A2 Attenuated smallpox vaccine strain
10/08/1985US4545987 Psoralen inactivated double-stranded RNA viral vaccines
10/02/1985EP0156712A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able toproduce such particles and process for their obtention
10/02/1985EP0156478A2 Propagation of group II avian adeno (AA) virus in avian cell culture and vaccine produced
09/1985
09/12/1985WO1985003876A1 Composition useful for obtaining vaccines containing particles carrying the surface antigene of hepatitis b virus and the recepto r of polymerized human serum albumin, animal cells capable of p roducing such particles and method for the obtention thereof
09/10/1985CA1193210A1 Human hepatoma derived cell line, process for preparation thereof, and uses therefor
08/1985
08/14/1985EP0151108A1 Particle adsorption
07/1985
07/30/1985US4532215 Directly passaging virus in African green monkey kidney culture cells to form serological test or radioimmunoassay of anti-hepatitis A virus
07/24/1985EP0149040A2 Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same
06/1985
06/25/1985CA1189450A1 Infectious bronchitis vaccines
06/19/1985EP0145356A2 Method of assay of DNA or RNA from virus particles
06/18/1985CA1188985A1 Production of viral antigens
06/11/1985US4522809 Process for obtaining lipid envelope virus sub-units, notably antigens for use as vaccines, the products obtained and their applications